chr10-60562860-T-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000373827.6(ANK3):​c.96+52326A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.676 in 151,628 control chromosomes in the GnomAD database, including 35,382 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.68 ( 35382 hom., cov: 33)

Consequence

ANK3
ENST00000373827.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.126

Publications

4 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.859 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ANK3NM_001204404.2 linkc.63+9605A>T intron_variant Intron 1 of 43 NP_001191333.1 Q12955-4
ANK3NM_001204403.2 linkc.96+52326A>T intron_variant Intron 2 of 43 NP_001191332.1 Q12955-5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ANK3ENST00000373827.6 linkc.96+52326A>T intron_variant Intron 2 of 43 1 ENSP00000362933.2 Q12955-5
ANK3ENST00000503366.6 linkc.63+9605A>T intron_variant Intron 1 of 43 2 ENSP00000425236.1 Q12955-4
ANK3ENST00000510382.1 linkn.101+52326A>T intron_variant Intron 2 of 2 2
ANK3ENST00000622427.4 linkn.63+9605A>T intron_variant Intron 1 of 32 2 ENSP00000483244.1 A0A087X0B4

Frequencies

GnomAD3 genomes
AF:
0.677
AC:
102508
AN:
151510
Hom.:
35373
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.523
Gnomad AMI
AF:
0.786
Gnomad AMR
AF:
0.724
Gnomad ASJ
AF:
0.812
Gnomad EAS
AF:
0.824
Gnomad SAS
AF:
0.881
Gnomad FIN
AF:
0.727
Gnomad MID
AF:
0.699
Gnomad NFE
AF:
0.716
Gnomad OTH
AF:
0.695
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.676
AC:
102562
AN:
151628
Hom.:
35382
Cov.:
33
AF XY:
0.685
AC XY:
50720
AN XY:
74064
show subpopulations
African (AFR)
AF:
0.523
AC:
21636
AN:
41330
American (AMR)
AF:
0.724
AC:
11048
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.812
AC:
2814
AN:
3464
East Asian (EAS)
AF:
0.823
AC:
4234
AN:
5142
South Asian (SAS)
AF:
0.881
AC:
4249
AN:
4822
European-Finnish (FIN)
AF:
0.727
AC:
7618
AN:
10482
Middle Eastern (MID)
AF:
0.687
AC:
202
AN:
294
European-Non Finnish (NFE)
AF:
0.716
AC:
48579
AN:
67808
Other (OTH)
AF:
0.695
AC:
1467
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1645
3291
4936
6582
8227
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
806
1612
2418
3224
4030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.687
Hom.:
4507
Bravo
AF:
0.668
Asia WGS
AF:
0.814
AC:
2815
AN:
3468

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
2.4
DANN
Benign
0.34
PhyloP100
0.13
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs958852; hg19: chr10-62322618; API